688606: Hangzhou Alltest Biotech Co.Ltd(688606) reply to the inquiry letter from the controlling shareholder and actual controller about the abnormal fluctuation of Hangzhou Alltest Biotech Co.Ltd(688606) stock transaction Hangzhou Alltest Biotech Co.Ltd(688606) : the company has received the inquiry letter about the abnormal fluctuation of Hangzhou Alltest Biotech Co.Ltd(688606) stock transaction sent by your company on January 19, 2022. After careful self-examination, the company replies as follows: the company is the controlling shareholder of Hangzhou Alltest Biotech Co.Ltd(688606) (hereinafter referred to as "listed company"), Up to now, there are no major events affecting the abnormal fluctuation of stock trading of listed companies, and there are no other major information that should be disclosed but not disclosed, including but not limited to planning major events involving mergers and acquisitions, share issuance, debt restructuring, business restructuring, asset divestiture and asset injection of listed companies. Hereby reply!
© China Stock Market News